Senvelgo 15 mg/ml

Active substance:

Velagliflozinum

Target spieces:

Drug form:

Perorální roztok

Registration date:

22. 11. 2023

Registration number:

EU/2/23/305/001

Verdict holder:

Boehringer Ingelheim Vetmedica, GmbH
Binger Strasse 173
Ingelheim am Rhein 55216

ATC vet. code:

QA10BK90 - Velagliflozin

Pharmacotherapeutic group:

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

Narcotic and psychotropic substances:

No

Prudent use:

No

Withdrawal period:

Authorisation procedure type:

Centralised

VMP details